Citations

Dolling, D. I, R. L Goodall, M. Chirara, J. Hakim, P. Nkurunziza, P. Munderi, D. Eram, D. Tumukunde, M. J Spyer, C. F Gilks, P. Kaleebu, D. T Dunn, D. Pillay, P. Kaleebu, D. Pillay, P. Awio, M. Chirara, D. Dunn, D. M Gibbs, C. Gilks, A. Kapaata, M. Katuramur, F. Lyagoba, B. Magambo, K. Mataruka, L. Mugarura, T. Musunga, M. Nabankkema, J. Nkalubo, P. Nkurunziza, C. Parry, V. Robertson, M. Spyer, D. Mulima, D. E Williams, I. Nankya, S. Nassimbwa, E. Ndashimye, E. Nabulime, M. Phiri, K. Mutasa, and S. Mukasa. "The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data." BMC Infectious Diseases 17, no. 1 (2017).

Gregson, J., P. Kaleebu, V. C Marconi, C. van Vuuren, N. Ndembi, R. L Hamers, P. Kanki, C. J Hoffmann, S. Lockman, D. Pillay, T. de Oliveira, N. Clumeck, G. Hunt, B. Kerschberger, R. W Shafer, C. Yang, E. Raizes, R. Kantor, and R. K Gupta. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study." Lancet Infect Dis 17, no. 3 (2017): 296-304.

Gupta, R. K, J. Gregson, N. Parkin, H. Haile-Selassie, A. Tanuri, L. Andrade Forero, P. Kaleebu, C. Watera, A. Aghokeng, N. Mutenda, J. Dzangare, S. Hone, Z. Z Hang, J. Garcia, Z. Garcia, P. Marchorro, E. Beteta, A. Giron, R. Hamers, R. Inzaule, L. M Frenkel, M. H Chung, T. de Oliveira, D. Pillay, K. Naidoo, A. Kharsany, R. Kugathasan, T. Cutino, G. Hunt, S. Avila Rios, M. Doherty, M. R Jordan, and S. Bertagnolio. "HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis." Lancet Infect Dis 18, no. 3 (2018): 346-355.

Ekoru, K., G. A V Murphy, E. H Young, H. Delisle, C. S Jerome, F. Assah, B. Longo-Mbenza, J. P D Nzambi, J. B K On'Kin , F. Buntix, M. C Muyer, C. S Wesseh, A. Sabir, C. Okafor, I. D Gezawa, F. Puepet, O. Enang, T. Raimi, E. Ohwovoriole, O. O Oladapo, P. Bovet, W. Mollentze, N. Unwin, W. K Gray, R. Walker, K. Agoudavi, S. Siziya, J. Chifamba, M. Njelekela, C. M Fourie, S. Kruger, A. E Schutte, C. Walsh, D. Gareta, A. Kamali, J. Seeley, S. A Norris, N. J Crowther, D. Pillay, P. Kaleebu, A. A Motala, and M. S Sandhu. "Deriving an optimal threshold of waist circumference for detecting cardiometabolic risk in sub-Saharan Africa." (2017) Int J Obes (Lond).

Goodall, R. L, D. T Dunn, P. Nkurunziza, L. Mugarura, T. Pattery, P. Munderi, C. Kityo, C. Gilks, P. Kaleebu, D. Pillay, R. K Gupta, and Dart Virology Group. "Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa." J Antimicrob Chemother 72, no. 5 (2017): 1450-1455.

Price, H., D. Dunn, T. Zachary, T. Vudriko, M. Chirara, C. Kityo, P. Munderi, M. Spyer, J. Hakim, C. Gilks, P. Kaleebu, D. Pillay, R. Gilson, and Dart Virology Group. "Hepatitis B serological markers and plasma DNA concentrations." AIDS 31, no. 8 (2017): 1109-1117.

Ratmann, O., C. Wymant, C. Colijn, S. Danaviah, M. Essex, S. D W Frost, A. Gall, S. Gaiseitsiwe, M. Grabowski, R. Gray, S. Guindon, A. von Haeseler, P. Kaleebu, M. Kendall, A. Kozlov, J. Manasa, B. Q Minh, S. Moyo, V. Novitsky, R. Nsubuga, S. Pillay, T. S Quinn, D. Serwadda, D. Ssemwanga, A. Stamatakis, J. Trifinopoulos, M. Wawer, A. Leigh Brown, T. de Oliveira, P. Kellam, D. Pillay, and C. Fraser. "HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences." AIDS Res Hum Retroviruses 33, no. 11 (2017): 1083-1098.